Company / Cash & Equivalents
Intuitive Surgical Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$3.4B
FY2025
5-year range
$1.3B / $3.4B
FY2021-FY2025
Trend
+66.1%
vs FY2024
Sector context
#15 of 148
Health Care
What the data says
Among 148 Health Care companies, Intuitive Surgical is in the top 10% for cash & equivalents. Cash & Equivalents has fluctuated over the past 10 years, ranging from $600M in FY2016 to $3.4B in FY2025.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +15.7%. Top quartile in the Health Care sector.
Improved from $2.8B to $3.4B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +28.7%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 148This company $3.4B Sector average $1.2B
▼
+186.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.7%, indicating consistent growth.
- In FY2025, cash & equivalents increased 66.1% year-over-year.
- Ranks #15 out of 148 companies in the Health Care sector.
- Lowest cash & equivalents in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.34 (safe zone, above 2.9 threshold)
- Strong profit margin: 28.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | +66.1% |
| FY2024 | $2.0B | -26.3% |
| FY2023 | $2.8B | +73.9% |
| FY2022 | $1.6B | +22.5% |
| FY2021 | $1.3B | -20.4% |
| FY2020 | $1.6B | +39.0% |
| FY2019 | $1.2B | +36.1% |
| FY2018 | $857.9M | +32.4% |
| FY2017 | $648.2M | +8.0% |
| FY2016 | $600.3M | -16.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026